Patent assignee · GB · COMPANY

ASTEX THERAPEUTICS LIMITED

🏢 View company profile →
125Patents
119Active
125Granted
59Portfolio score

Filing activity: Oct 23, 2003 → Jan 25, 2023 · 41 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8399442B2 Pharmaceutical compounds Chemistry; Metallurgy 41 Active
US8324225B2 Pyrrolopyrimidine compounds and their uses Chemistry; Metallurgy 36 Active
US7951819B2 Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds Human Necessities 34 Active
US8277807B2 Pharmaceutical combinations Human Necessities 31 Active
US8415355B2 Pyrrolopyrimidine compounds and their uses Human Necessities 29 Active
US9309241B2 Naphthyridine derivative compounds Chemistry; Metallurgy 27 Active
US8685980B2 Pyrrolopyrimidine compounds and their uses Human Necessities 27 Active
US9303029B2 Substituted quinoxalines as FGFR kinase inhibitors Chemistry; Metallurgy 26 Active
US7977477B2 Benzimidazole derivatives and their use as protein kinase inhibitors Chemistry; Metallurgy 26 Active
US9290478B2 Substituted quinoxalines as FGFR kinase inhibitors Chemistry; Metallurgy 26 Active
US9447098B2 Pteridines as FGFR inhibitors Chemistry; Metallurgy 26 Active
US9309242B2 Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors Chemistry; Metallurgy 26 Active
US9303030B2 Compounds Chemistry; Metallurgy 26 Active
US8895745B2 Bicyclic heterocyclic compounds as FGFR inhibitors Chemistry; Metallurgy 24 Active
US8895601B2 Pyrazolyl quinoxaline kinase inhibitors Chemistry; Metallurgy 23 Active
US9464071B2 Pyrazolyl quinoxaline kinase inhibitors Chemistry; Metallurgy 23 Active
US9439896B2 Quinolines as FGFR kinase modulators Chemistry; Metallurgy 23 Active
US9493426B2 Quinazolinone derivatives useful as FGFR kinase modulators Chemistry; Metallurgy 21 Active
US9527844B2 Naphthyridine derivative compounds Chemistry; Metallurgy 21 Active
US7625922B2 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds Human Necessities 17 Expired
US9850228B2 Pyrazolyl quinoxaline kinase inhibitors Chemistry; Metallurgy 17 Active
US9856236B2 Substituted quinoxalines as FGFR kinase inhibitors Chemistry; Metallurgy 17 Active
US9737544B2 Compounds Chemistry; Metallurgy 16 Active
US9757364B2 Naphthyridine derivative compounds Chemistry; Metallurgy 16 Active
US9902714B2 Quinoxaline derivatives useful as FGFR kinase modulators Human Necessities 15 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.